Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-20-003039

Options or other derivatives

  • Director acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Silverman Joshua Director 2020-02-21 Grant or award · PTIX Common stock Options +120,000 120,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…